Topic
pharmaceutical industry
13 stories related to this topic, newest first.
usatoday.comscience33 days ago
Supreme Court Declines to Hear Pharma Challenges to Medicare Drug Price Program
The U.S. Supreme Court declined to review lawsuits filed by six pharmaceutical companies against the Medicare drug price negotiation program. The White House separately announced an expansion of its TrumpRx discount platform through partnerships with three prescription savings se…
forbes.comscience34 days ago
U.S. Biotech Firms Spent $60 Billion on Chinese Drugs in First Quarter
American drug companies purchased Chinese-developed molecules at a pace that would double last year's total. The purchases have created divisions within the industry over whether to treat Chinese firms as partners or competitors.
Nbc Newspolitics40 days agoUpdated
Trump Removes FDA Commissioner Marty Makary
President Donald Trump announced Tuesday that Dr. Marty Makary has left his position as FDA commissioner following weeks of reported tensions with the White House. Kyle Diamantas, the agency's former top food official, will serve as acting commissioner.
medpagetoday.comscience48 days ago
GLP-1 Obesity Drugs Generate Higher R&D Returns Than Oncology
Obesity treatments have become the leading driver of pharmaceutical research and development gains, surpassing oncology. A Deloitte partner highlighted concentration risks for companies reliant on these drugs. Plus-size model Ashley Graham described the trend as disheartening for…
rte.ieworld51 days ago
Purdue Pharma Bankruptcy Settlement Finalized, Launching Knoa Pharma with $5 Billion Family Contribution
Purdue Pharma's settlement resolving thousands of lawsuits over opioids takes effect on May 1, 2026, with the company being replaced by Knoa Pharma. The deal provides at least $7.4 billion, mostly from Sackler family members. It includes public release of 30 million company docum…
rte.ieworld4 days ago
Purdue Pharma Agrees to $5 Billion Penalty and Restructuring in DOJ Opioid Settlement
A federal court in New Jersey sentenced Purdue Pharma to pay more than $5 billion in criminal penalties for unlawfully promoting opioids and related misconduct. The ruling follows a 2020 plea agreement and includes plans for the company to cease operations. Officials highlighted…
DA
ai-cio.comscience56 days ago
Sun Pharma Agrees to Acquire Organon in $75 Billion Cash Deal
Sun Pharma has signed a definitive agreement to acquire Organon for $75 billion in cash. The deal sets the acquisition price at $00 per share and is expected to close in early 2027. It remains subject to regulatory and stockholder approvals.
FI
Substrate placeholder — needs reviewworld60 days ago
China's State Council Issues Guidelines on Innovative Drug Pricing
China's State Council has released new guidelines aimed at supporting innovative drug pricing through value-based methods while reducing generic drug prices via market competition. A Citigroup analyst described the guidelines as the most significant in a decade.
Substrate placeholder — needs reviewscience66 days ago
Senate Report Finds Most Drugmakers Raised Prices Despite Trump-Era Deals
A recent Senate report indicates that 15 of 16 drugmakers involved in a Trump administration initiative have increased prescription drug prices since early 2025. The report also questions the effectiveness of the TrumpRx online platform in providing savings to patients.
Substrate placeholder — needs reviewfinance71 days ago
European Pharmaceutical Sector Faces Challenges from US Policies and China's Biotech Growth
Europe's pharmaceutical industry is encountering difficulties due to fragmented capital markets, pricing regulations, and reimbursement policies. CNBC reported that US policies under former President Trump and China's expanding biotech sector are contributing to the decline of Eu…
Substrate placeholder — needs reviewscience73 days ago
PhRMA CEO Steve Ubl to Step Down at End of Year After Over a Decade in Role
Steve Ubl, chief executive of the Pharmaceutical Research and Manufacturers of America (PhRMA), will step down at the end of the year. He has led the trade group representing brand-name drug makers for more than a decade. The announcement comes amid ongoing discussions on drug pr…
ST
Substrate placeholder — needs reviewscience75 days ago
Gilead Sciences Acquires German Biotech Tubulis for Over $3 Billion
Gilead Sciences announced the acquisition of Tubulis, a German biotechnology company, for more than $3 billion. The deal aims to expand Gilead's oncology drug development pipeline. Tubulis specializes in antibody-drug conjugates for cancer treatments.
ST
Substrate placeholder — needs reviewscience76 days ago
Biotech Developments Include Peptide Research Concerns and Opposition to Proposed NIH Budget Cuts
Recent biotech news covers scrutiny over limited evidence supporting peptide therapies, opposition to proposed reductions in National Institutes of Health funding, and other industry updates. These stories highlight ongoing debates in scientific validation and federal support for…
ST